B.M.P. PHARMA TRAD (BMP.SG) (BMP) — Strategic Asset Allocation Index
B.M.P. PHARMA TRAD (BMP.SG) (BMP) has a Strategic Asset Allocation Index of 66.4% as of December 2016. Strategic assets (PP&E of €635.00 plus long-term investments of €3.41 Million) total €3.41 Million, measured against net assets of €5.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
B.M.P. PHARMA TRAD (BMP.SG) Strategic Asset Allocation Index (2013–2016)
This chart shows how B.M.P. PHARMA TRAD (BMP.SG)'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2013 to 2016. As of December 2016, the index stands at 66.4%, representing strategic assets of €3.41 Million against net assets of €5.14 Million EUR. See BMP net assets for net asset value and shareholders' equity analysis.
Annual Strategic Asset Allocation Index for B.M.P. PHARMA TRAD (BMP.SG) (2013–2016)
The table below presents the year-by-year Strategic Asset Allocation Index for B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2016, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BMP market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2016 | 66.4% | €3.41 Million | €635.00 | €3.41 Million | €5.14 Million | ▲ +0.1 pp |
| 2015 | 66.3% | €3.41 Million | €- | €3.41 Million | €5.15 Million | ▼ -5.4 pp |
| 2014 | 71.7% | €3.41 Million | €- | €3.41 Million | €4.76 Million | ▼ -0.6 pp |
| 2013 | 72.3% | €3.41 Million | €- | €3.41 Million | €4.72 Million | — |